The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
[5-(2-Methoxycarbonylamino-1H-benzoimidazole-5-carbonyl)-thiophen-3-yl]-acetic acid tert-butyl ester ID: ALA133900
PubChem CID: 44354712
Max Phase: Preclinical
Molecular Formula: C20H21N3O5S
Molecular Weight: 415.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)Nc1nc2cc(C(=O)c3cc(CC(=O)OC(C)(C)C)cs3)ccc2[nH]1
Standard InChI: InChI=1S/C20H21N3O5S/c1-20(2,3)28-16(24)8-11-7-15(29-10-11)17(25)12-5-6-13-14(9-12)22-18(21-13)23-19(26)27-4/h5-7,9-10H,8H2,1-4H3,(H2,21,22,23,26)
Standard InChI Key: XZBCJXRKHAFCOB-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
8.6292 -5.7917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1417 -5.1292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5125 -5.3875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1417 -6.4625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4542 -5.7875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3625 -5.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7542 -5.0500 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.2250 -4.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4250 -6.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0417 -5.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3625 -6.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9375 -5.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6167 -6.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4625 -7.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2042 -5.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6417 -4.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1292 -7.9750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8250 -4.4042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2792 -7.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9375 -6.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2167 -4.1417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.9792 -6.5542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6417 -6.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3125 -8.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8292 -5.4167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.9750 -8.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8250 -7.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9542 -8.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4167 -4.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 8 1 0
4 1 1 0
5 1 1 0
6 2 1 0
7 3 1 0
8 12 1 0
9 3 2 0
10 5 1 0
11 4 1 0
12 16 1 0
13 9 1 0
14 19 1 0
15 7 1 0
16 6 2 0
17 14 1 0
18 10 2 0
19 13 1 0
20 23 1 0
21 8 2 0
22 14 2 0
23 11 2 0
24 17 1 0
25 10 1 0
26 24 1 0
27 24 1 0
28 24 1 0
29 25 1 0
11 6 1 0
12 20 2 0
13 15 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 415.47Molecular Weight (Monoisotopic): 415.1202AlogP: 3.92#Rotatable Bonds: 5Polar Surface Area: 110.38Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.11CX Basic pKa: 3.34CX LogP: 4.01CX LogD: 4.00Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.48Np Likeness Score: -1.04
References 1. Kruse LI, Ladd DL, Harrsch PB, McCabe FL, Mong SM, Faucette L, Johnson R.. (1989) Synthesis, tubulin binding, antineoplastic evaluation, and structure-activity relationship of oncodazole analogues., 32 (2): [PMID:2913301 ] [10.1021/jm00122a020 ]